Aelix Therapeutics
Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.
Operating in biotechnology, health care, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), Aelix Therapeutics was founded in 2014.
Its activity falls under biotechnology, health care, therapeutics; the profile below is assembled from public directory data.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_Unknown stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $13.4M in funding.
| Sector | Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $13,408,000 |
Website: www.aelixtherapeutics.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account